Botanix Pharmaceuticals Limited (ASX:BOT)

Botanix Pharmaceuticals Revenue

In the fiscal year ending June 30, 2025, Botanix Pharmaceuticals had annual revenue of 5.79M AUD with 179.74% growth. Botanix Pharmaceuticals had revenue of 5.41M in the half year ending June 30, 2025, with 9,028.10% growth.

• Revenue: 5.79M
• Revenue Growth: +179.74%
• P/S Ratio: 44.25
• Revenue / Employee: 526.29K
• Employees: 11
• Market Cap: 256.19M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	5.79M	3.72M	179.74%
Jun 30, 2024	2.07M	-1.70M	-45.14%
Jun 30, 2023	3.77M	1.02M	36.94%
Jun 30, 2022	2.75M	-4.13M	-60.00%
Jun 30, 2021	6.89M	-686.66K	-9.07%